Li S - Search Results

1

Dual targeting of protein translation and nuclear protein export results in enhanced antimyeloma effects.

Li S, Fu J, Walker CJ, Yang J, Bhutani D, Chakraborty R, Mamillapalli N, Mapara MY, Landesman Y, Lentzsch S. Li S, et al. Blood Adv. 2023 Jun 27;7(12):2926-2937. doi: 10.1182/bloodadvances.2021006638. Blood Adv. 2023. PMID: 36827679 Free PMC article.

2

PDLIM2 suppresses human T-cell leukemia virus type I Tax-mediated tumorigenesis by targeting Tax into the nuclear matrix for proteasomal degradation.

Yan P, Fu J, Qu Z, Li S, Tanaka T, Grusby MJ, Xiao G. Yan P, et al. Among authors: li s. Blood. 2009 Apr 30;113(18):4370-80. doi: 10.1182/blood-2008-10-185660. Epub 2009 Jan 8. Blood. 2009. PMID: 19131544 Free PMC article.

3

C/EBPbeta regulates transcription factors critical for proliferation and survival of multiple myeloma cells.

Pal R, Janz M, Galson DL, Gries M, Li S, Jöhrens K, Anagnostopoulos I, Dörken B, Mapara MY, Borghesi L, Kardava L, Roodman GD, Milcarek C, Lentzsch S. Pal R, et al. Among authors: li s. Blood. 2009 Oct 29;114(18):3890-8. doi: 10.1182/blood-2009-01-201111. Epub 2009 Aug 28. Blood. 2009. PMID: 19717648 Free PMC article.

4

Recent advances of IMiDs in cancer therapy.

Li S, Gill N, Lentzsch S. Li S, et al. Curr Opin Oncol. 2010 Nov;22(6):579-85. doi: 10.1097/CCO.0b013e32833d752c. Curr Opin Oncol. 2010. PMID: 20689431 Review.

5

IMiD immunomodulatory compounds block C/EBP{beta} translation through eIF4E down-regulation resulting in inhibition of MM.

Li S, Pal R, Monaghan SA, Schafer P, Ouyang H, Mapara M, Galson DL, Lentzsch S. Li S, et al. Blood. 2011 May 12;117(19):5157-65. doi: 10.1182/blood-2010-10-314278. Epub 2011 Mar 9. Blood. 2011. PMID: 21389327 Free PMC article.

6

Targeting the microtubular network as a new antimyeloma strategy.

Feng R, Li S, Lu C, Andreas C, Stolz DB, Mapara MY, Lentzsch S. Feng R, et al. Among authors: li s. Mol Cancer Ther. 2011 Oct;10(10):1886-96. doi: 10.1158/1535-7163.MCT-11-0234. Epub 2011 Aug 8. Mol Cancer Ther. 2011. PMID: 21825007

7

Lenalidomide-induced upregulation of CXCR4 in CD34+ hematopoietic cells, a potential mechanism of decreased hematopoietic progenitor mobilization.

Li S, Fu J, Ma H, Mapara MY, Lentzsch S. Li S, et al. Leukemia. 2013 Jun;27(6):1407-11. doi: 10.1038/leu.2012.323. Epub 2012 Nov 9. Leukemia. 2013. PMID: 23138185 No abstract available.

8

Elevated Translation Initiation Factor eIF4E Is an Attractive Therapeutic Target in Multiple Myeloma.

Li S, Fu J, Lu C, Mapara MY, Raza S, Hengst U, Lentzsch S. Li S, et al. Mol Cancer Ther. 2016 Apr;15(4):711-9. doi: 10.1158/1535-7163.MCT-15-0798. Epub 2016 Mar 3. Mol Cancer Ther. 2016. PMID: 26939700

9

Multiple myeloma-derived MMP-13 mediates osteoclast fusogenesis and osteolytic disease.

Fu J, Li S, Feng R, Ma H, Sabeh F, Roodman GD, Wang J, Robinson S, Guo XE, Lund T, Normolle D, Mapara MY, Weiss SJ, Lentzsch S. Fu J, et al. Among authors: li s. J Clin Invest. 2016 May 2;126(5):1759-72. doi: 10.1172/JCI80276. Epub 2016 Apr 4. J Clin Invest. 2016. PMID: 27043283 Free PMC article.

10

Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kδ and CK1ε in hematological malignancies.

Deng C, Lipstein MR, Scotto L, Jirau Serrano XO, Mangone MA, Li S, Vendome J, Hao Y, Xu X, Deng SX, Realubit RB, Tatonetti NP, Karan C, Lentzsch S, Fruman DA, Honig B, Landry DW, O'Connor OA. Deng C, et al. Among authors: li s. Blood. 2017 Jan 5;129(1):88-99. doi: 10.1182/blood-2016-08-731240. Epub 2016 Oct 26. Blood. 2017. PMID: 27784673 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

91,643 results

Search Page